National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - Executive summary

Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold E. Bays, Peter H. Jones, James M. McKenney, Scott M Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson, W. Virgil Brown

Research output: Contribution to journalArticle

276 Citations (Scopus)

Abstract

Various organizations and agencies have issued recommendations for the management of dyslipidemia. Although many commonalities exist among them, material differences are present as well. The leadership of the National Lipid Association (NLA) convened an Expert Panel to develop a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine. The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel and includes: (1) background and conceptual framework for formulation of the NLA Expert Panel recommendations; (2) screening and classification of lipoprotein lipid levels in adults; (3) targets for intervention in dyslipidemia management; (4) atherosclerotic cardiovascular disease risk assessment and treatment goals based on risk category; (5) atherogenic cholesterol - non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol - as the primary targets of therapy; and (6) lifestyle and drug therapies intended to reduce morbidity and mortality associated with dyslipidemia.

Original languageEnglish (US)
Pages (from-to)473-488
Number of pages16
JournalJournal of Clinical Lipidology
Volume8
Issue number5
DOIs
StatePublished - Sep 1 2014

Fingerprint

Dyslipidemias
Lipids
Clinical Medicine
LDL Cholesterol
Lipoproteins
Life Style
Consensus
Cardiovascular Diseases
Cholesterol
Organizations
Morbidity
Drug Therapy
Mortality
Therapeutics

Keywords

  • Atherogenic cholesterol
  • Atherosclerotic cardiovascular disease
  • Clinical recommendations
  • Coronary heart disease
  • Dyslipidemia
  • Lipoproteins
  • Low-density lipoprotein cholesterol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., ... Brown, W. V. (2014). National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - Executive summary. Journal of Clinical Lipidology, 8(5), 473-488. https://doi.org/10.1016/j.jacl.2014.07.007

National Lipid Association recommendations for patient-centered management of dyslipidemia : Part 1 - Executive summary. / Jacobson, Terry A.; Ito, Matthew K.; Maki, Kevin C.; Orringer, Carl E.; Bays, Harold E.; Jones, Peter H.; McKenney, James M.; Grundy, Scott M; Gill, Edward A.; Wild, Robert A.; Wilson, Don P.; Brown, W. Virgil.

In: Journal of Clinical Lipidology, Vol. 8, No. 5, 01.09.2014, p. 473-488.

Research output: Contribution to journalArticle

Jacobson, TA, Ito, MK, Maki, KC, Orringer, CE, Bays, HE, Jones, PH, McKenney, JM, Grundy, SM, Gill, EA, Wild, RA, Wilson, DP & Brown, WV 2014, 'National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - Executive summary', Journal of Clinical Lipidology, vol. 8, no. 5, pp. 473-488. https://doi.org/10.1016/j.jacl.2014.07.007
Jacobson, Terry A. ; Ito, Matthew K. ; Maki, Kevin C. ; Orringer, Carl E. ; Bays, Harold E. ; Jones, Peter H. ; McKenney, James M. ; Grundy, Scott M ; Gill, Edward A. ; Wild, Robert A. ; Wilson, Don P. ; Brown, W. Virgil. / National Lipid Association recommendations for patient-centered management of dyslipidemia : Part 1 - Executive summary. In: Journal of Clinical Lipidology. 2014 ; Vol. 8, No. 5. pp. 473-488.
@article{326fdc18476c48f3b8b2253c583a7878,
title = "National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - Executive summary",
abstract = "Various organizations and agencies have issued recommendations for the management of dyslipidemia. Although many commonalities exist among them, material differences are present as well. The leadership of the National Lipid Association (NLA) convened an Expert Panel to develop a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine. The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel and includes: (1) background and conceptual framework for formulation of the NLA Expert Panel recommendations; (2) screening and classification of lipoprotein lipid levels in adults; (3) targets for intervention in dyslipidemia management; (4) atherosclerotic cardiovascular disease risk assessment and treatment goals based on risk category; (5) atherogenic cholesterol - non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol - as the primary targets of therapy; and (6) lifestyle and drug therapies intended to reduce morbidity and mortality associated with dyslipidemia.",
keywords = "Atherogenic cholesterol, Atherosclerotic cardiovascular disease, Clinical recommendations, Coronary heart disease, Dyslipidemia, Lipoproteins, Low-density lipoprotein cholesterol",
author = "Jacobson, {Terry A.} and Ito, {Matthew K.} and Maki, {Kevin C.} and Orringer, {Carl E.} and Bays, {Harold E.} and Jones, {Peter H.} and McKenney, {James M.} and Grundy, {Scott M} and Gill, {Edward A.} and Wild, {Robert A.} and Wilson, {Don P.} and Brown, {W. Virgil}",
year = "2014",
month = "9",
day = "1",
doi = "10.1016/j.jacl.2014.07.007",
language = "English (US)",
volume = "8",
pages = "473--488",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - National Lipid Association recommendations for patient-centered management of dyslipidemia

T2 - Part 1 - Executive summary

AU - Jacobson, Terry A.

AU - Ito, Matthew K.

AU - Maki, Kevin C.

AU - Orringer, Carl E.

AU - Bays, Harold E.

AU - Jones, Peter H.

AU - McKenney, James M.

AU - Grundy, Scott M

AU - Gill, Edward A.

AU - Wild, Robert A.

AU - Wilson, Don P.

AU - Brown, W. Virgil

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Various organizations and agencies have issued recommendations for the management of dyslipidemia. Although many commonalities exist among them, material differences are present as well. The leadership of the National Lipid Association (NLA) convened an Expert Panel to develop a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine. The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel and includes: (1) background and conceptual framework for formulation of the NLA Expert Panel recommendations; (2) screening and classification of lipoprotein lipid levels in adults; (3) targets for intervention in dyslipidemia management; (4) atherosclerotic cardiovascular disease risk assessment and treatment goals based on risk category; (5) atherogenic cholesterol - non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol - as the primary targets of therapy; and (6) lifestyle and drug therapies intended to reduce morbidity and mortality associated with dyslipidemia.

AB - Various organizations and agencies have issued recommendations for the management of dyslipidemia. Although many commonalities exist among them, material differences are present as well. The leadership of the National Lipid Association (NLA) convened an Expert Panel to develop a consensus set of recommendations for patient-centered management of dyslipidemia in clinical medicine. The current Executive Summary highlights the major conclusions in Part 1 of the recommendations report of the NLA Expert Panel and includes: (1) background and conceptual framework for formulation of the NLA Expert Panel recommendations; (2) screening and classification of lipoprotein lipid levels in adults; (3) targets for intervention in dyslipidemia management; (4) atherosclerotic cardiovascular disease risk assessment and treatment goals based on risk category; (5) atherogenic cholesterol - non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol - as the primary targets of therapy; and (6) lifestyle and drug therapies intended to reduce morbidity and mortality associated with dyslipidemia.

KW - Atherogenic cholesterol

KW - Atherosclerotic cardiovascular disease

KW - Clinical recommendations

KW - Coronary heart disease

KW - Dyslipidemia

KW - Lipoproteins

KW - Low-density lipoprotein cholesterol

UR - http://www.scopus.com/inward/record.url?scp=84908397421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908397421&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2014.07.007

DO - 10.1016/j.jacl.2014.07.007

M3 - Article

C2 - 25234560

AN - SCOPUS:84908397421

VL - 8

SP - 473

EP - 488

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 5

ER -